Antigen Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.45 M
as on 17-12-2024
- Revenue -27.59%
(FY 2020)
- Profit -51.97%
(FY 2020)
- Ebitda -21.47%
(FY 2020)
- Net Worth 6.22%
(FY 2020)
- Total Assets -9.05%
(FY 2020)
About Antigen Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.45 M.
Lalit Kumar and Madhulika Burnwal serve as directors at the Company.
- CIN/LLPIN
U74899DL2002PTC114384
- Company No.
114384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Antigen Healthcare Private Limited offer?
Antigen Healthcare Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Antigen Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Kumar  | Director | 26-Feb-2002 | Current |
| Madhulika Burnwal | Director | 01-Dec-2012 | Current |
Financial Performance of Antigen Healthcare.
Antigen Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 27.59% decrease. The company also saw a substantial fall in profitability, with a 51.97% decrease in profit. The company's net worth moved up by a moderate rise of 6.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Antigen Healthcare?
In 2018, Antigen Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lifeways Formulations Private LimitedActive 8 years 10 monthsLalit Kumar and Madhulika Burnwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 16 Jun 2010 | ₹1.70 M | Open |
Others Creation Date: 16 Jun 2010 | ₹2.75 M | Open |
How Many Employees Work at Antigen Healthcare?
Unlock and access historical data on people associated with Antigen Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Antigen Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antigen Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
